GlassScriptPhysician profile
Paul D Stoddard
NPI 1396478491
$983.94
in general payments reported to CMS, 2019-2025
19 companies · $331 in 2025
The $331 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $208 · 2023: $77.11 · 2024: $369 · 2025: $331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.36 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $271.78 | 2024-2025 | Xtandi |
| Sumitomo Pharma America, INC. | $163.71 | 2023-2025 | Gemtesa, Orgovyx |
| Progenics Pharmaceuticals, INC. | $127.55 | 2022 | |
| Endo USA, INC. | $43.65 | 2024 | Xiaflex, Aveed |
| Checkpoint Surgical, INC | $40.74 | 2024 | Checkpoint Stimulators |
| Janssen Biotech, INC. | $38.30 | 2023-2025 | Erleada |
| Urovant Sciences INC | $37.97 | 2022 | |
| Tolmar, INC. | $29.30 | 2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $28.67 | 2025 | Provenge |
| Convatec INC. | $26.20 | 2022 | |
| Abc Home Medical Supply, INC. | $25.87 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $24.54 | 2024 | Bard Urinary Drainage Bag |
| Novo Nordisk INC | $23.63 | 2024 | Rivfloza |
| Verity Pharmaceuticals INC. | $19.40 | 2025 | Trelstar |
| Sandoz INC. | $17.69 | 2024 | Hyrimoz |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $17.16 | 2024 | Gentlecath |
| Antares Pharma, INC. | $16.89 | 2023 | Nocdurna, Xyosted, Tlando |
| Bayer Healthcare Pharmaceuticals INC. | $15.87 | 2022 | |
| Innovation Technologies INC | $15.02 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Stoddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.